Business Wire

Cross Industry Customer Growth and Multi Solution Uptake Power Armis’ Business Momentum


Armis, the asset intelligence cybersecurity company, today announced another business milestone since it reached its $100M ARR milestone in February, announcing it has achieved 80% customer growth in just the first 6 months of its fiscal year, ending July 2023. Customers across the globe also expanded their use of the Armis Platform with a 50% adoption rate of two solutions in the Armis portfolio, with over 15% adopting three or more of its solutions in the past year.

“We focus on empowering businesses with asset intelligence and actionable plans so they can be assured that their infrastructure is safe and operational at all times,” said Yevgeny Dibrov, Co-Founder and CEO at Armis. “Today I see Armis chosen as the platform of choice for Fortune 100, 200 and 500 companies all around the world who are looking to understand their attack surface and proactively defend themselves against increased threats. I measure our success not only in financial growth, but in the positive impact that the company is having on virtually all industries thanks to the trust that our customers have given us.”

The Attack Surface is Expanding and Threats are on the Rise

Armis expects that by 2025, the number of connected assets will grow to 50B but 80% of assets remain unseen, unmanaged and lacking in any security measures. Vulnerabilities are also increasing with a growth of 689% in the last 6 years, many targeted at critical infrastructure with cyberattacks specifically up 140% in this sector. This increase has created a fast changing and difficult situation in which organizations are struggling to stay ahead.

Armis is solving customers critical cybersecurity challenges with four key offerings:

  1. Asset management and security - Complete asset inventory of all asset types allowing any organization to see and secure the attack surface
  2. OT/IOT security - See and secure OT/IOT networks and physical assets, ensure uptime and build an effective & comprehensive security strategy
  3. Medical device security - Complete visibility and security for all medical devices, clinical assets and the entire healthcare ecosystem - with zero disruption to patient care
  4. Vulnerability prioritization and remediation - Consolidate, prioritize and remediate all vulnerabilities; improve mean time to remediation (MTTR) with automatic remediation and ticketing workflows

These four solutions, all recognized by analysts and customers, are all built on top of the same platform ensuring customers can benefit from an integrated platform which unlocks value and enables customers to truly see, protect and manage their attack surface.

Armis becomes the cybersecurity industry standard, protecting the most critical assets on the planet

Some notable recent wins include Vestas, the leading manufacturer and service provider for sustainable wind energy in the world, Reckitt, the multinational consumer goods company, Booking Holdings, the world leader in online travel, the Port of Antwerp, the world's largest cargo port, and JLR, the biggest luxury vehicle manufacturer in the UK.

“As a leading manufacturer and service provider for sustainable wind energy, our customers require a high degree of security controls to meet regulatory requirements. We utilize Armis to detect and respond to threats and have worked extensively with Armis to shape the integration, so the product fits into our overall detect and response strategy. The insights provided by Armis have proven highly valuable in day-to-day operations again and again, and we are currently expanding our installation," said Steffen Høgh Vinter, Director CMRC Enablement and Problem Management, Vestas.

“When we started the program from a central cyber team, we had no visibility into our factory so every device was unseen. Now, with Armis deployed in half our factories, we've seen 10s of 1000s of devices that we didn't know about before. Armis is allowing us to address three use cases: firstly, giving us that visibility that we didn't have before. Secondly, allowing us to identify vulnerabilities, which allows us to de-risk our state. And thirdly allowing us to identify any unusual behavior that's happening in our network,“ said David Boyd, Director of Cyber Strategy & Engagement at Reckitt.

“Armis is one of those inventions that simply needed to happen. It meets a foundational, unmet need in cybersecurity, namely the ability to 'see all evil' (on the network) by discovering rogue devices and providing real time intelligence about their identity and condition. With Armis, there’s no need for an army of engineers or analysts to decipher complex systems and their signals,” said Spencer Mott, Chief Security Officer, Booking Holdings.

Analyst Recognition and Accolades

In 2023, Armis was recognized both in the Deloitte Technology Fast 500™ for its growth and high performance, and by Fast Company as the most innovative security company of 2023. Additionally, it has been named an honoree to the Inc. 5000 list, and its Armis Partner Experience Program (APEX) was given a 5 star rating in the 2023 CRN Partner Program Guide.

If you would like to know more about Armis’ award-winning solutions, visit or contact us at

About Armis

Armis, the asset intelligence cybersecurity company, protects the entire attack surface and manages the organization's cyber risk exposure in real time. In a rapidly evolving, perimeter-less world Armis ensures that organizations continuously see, secure, protect and manage all critical assets. Armis secures Fortune 100, 200 and 500 companies as well as national governments, state and local entities to help keep critical infrastructure, economies and society stay safe and secure 24/7. Armis is a privately held company headquartered in California.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Media Contact:
Rebecca Cradick
Senior Director, Global Communications

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ARMA Instruments Launch Zero Trust G1 Mark II Secure Messaging Communication Device3.10.2023 05:00:00 CEST | Press release

The Russian invasion of Ukraine has ignited an arms race in the theater of cyber warfare. Zero trust is the operative term for military, defense sectors, and governments across the globe. U.S. intelligence agencies and international partners recently published a report warning of the new Russian malware program Sandworm, likely targeting Ukrainian interests in its ongoing war, and U.S. defense agencies set a deadline of 2027 for implementation of zero trust cybersecurity environments [FedTech, August 2023]. This press release features multimedia. View the full release here: Switzerland-based ARMA Instruments AG announces the launch of their ARMA G1 Mark II Secure Messaging Device. Developed with zero trust principles, the device is a closed mobile system for person-to-person messaging at the highest security levels to counter advanced adversary attacks. The device will be beneficial for NGOs, defense agencies, cybersecurity oper

SLB Launches Carbon Storage Screening and Ranking Solution3.10.2023 04:00:00 CEST | Press release

SLB (NYSE: SLB) today launched its carbon storage screening and ranking solution that increases confidence in site selection decisions based on scientific analysis of the long-term integrity and economic potential of an asset. The solution helps customers avoid suboptimal storage sites with risk factors that can waste valuable time and resources as well as decrease the probability of a carbon capture, utilization and storage (CCUS) project reaching final investment decision (FID). “CCUS is one of the most immediate opportunities to reduce emissions, but it must scale up by 100–200 times in less than three decades to have the expected impact on global net zero ambitions,” said Frederik Majkut, senior vice president of Carbon Solutions for SLB’s New Energy business. “Ensuring that a storage site is both safer and economical is crucial for the speed, scale and investment needed to meaningfully drive CCUS growth for a low carbon energy ecosystem.” The screening and ranking solution uses bo

Takeda Provides Update on EXKIVITY ® (mobocertinib)2.10.2023 22:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY® (mobocertinib) in the U.S. for adult patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or after platinum-based chemotherapy. Takeda intends to similarly initiate voluntary withdrawal globally where EXKIVITY is approved and is working with regulators in other countries where it is currently available on next steps. This decision was based on the outcome of the Phase 3 EXCLAIM-2 confirmatory trial, which did not meet its primary endpoint and thus did not fulfill the confirmatory data requirements of the Accelerated Approval granted by the U.S. FDA nor the conditional marketing approvals granted in other countries. The EXCLAIM-2 trial was a Phase 3

Galderma announces progress with RelabotulinumtoxinA regulatory submissions2.10.2023 22:27:00 CEST | Press release

Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (QM-1114) to the U.S. Food and Drug Administration (“FDA”). The FDA has issued a Complete Response Letter (“CRL”) to Galderma related to its BLA for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines (frown lines) associated with corrugator and/or procerus muscle activity in adult patients as well as moderate-to-severe lateral canthal lines (crow’s feet) associated with orbicularis oculi muscle activity in adult patients. The CRL points out certain deficiencies isolated to items related to Chemistry, Manufacturing, and Controls (“CMC”) processes. All other aspects of the BLA, including safety and efficacy related parts, did not solicit deficiencies to be addressed. Galderma has already identified changes to the manufacturing process to address feedback. It will also

Visa Launches $100 million Generative AI Ventures Initiative2.10.2023 22:05:00 CEST | Press release

Visa (NYSE: V), a global leader in payments, today announced a new $100 million generative AI ventures initiative to invest in the next generation of companies focused on developing generative AI technologies and applications that will impact the future of commerce and payments. As a pioneer of AI use in payments since 1993, Visa considers this initiative an extension of Visa’s leadership in using AI to drive innovation in payments, create value for partners and clients, and enable and empower global commerce. Generative AI is an emerging subset of AI that is built on Large Language Models (LLMs) to develop artificial general intelligence capable of generating text, images or other content from large sets of existing data when given prompts. “While much of generative AI so far has been focused on tasks and content creation, this technology will soon not only reshape how we live and work, but it will also meaningfully change commerce in ways we need to understand,” said Jack Forestell,